Avidity Biosciences, Inc. (NASDAQ:RNA) filed a Form 8-K with the Securities and Exchange Commission on February 03, 2026, disclosing a material event.
Avidity Biosciences, Inc.'s stock currently trades at $72.93 with a market capitalization of $9.4B. The Healthcare company's stock moved following the disclosure.


